PRPH - プロフェイズ・ラブズ (ProPhase Labs Inc.)


   Prophase Labs: Strong Fundamentals And Growth Potential (NASDAQ:PRPH)  2022/10/13 16:42:36 Seeking Alpha
ProPhase Labs has strong fundamentals and a lot of upside potential with new business acquisitions. Click here to see its growth catalysts and potential headwinds.
   ProPhase Labs (PRPH) Investor Presentation - Slideshow (NASDAQ:PRPH)  2022/09/13 14:25:33 Seeking Alpha
The following slide deck was published by ProPhase Labs, Inc.
   ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)  2022/09/06 12:15:00 GlobeNewswire
GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be featured as a presenting company at the H.C. Wainwright 24 th Annual Global Investment Conference on September 12, 2022 at 2:30 pm, Eastern Time. The conference is being held as a hybrid in-person/virtual event from September 12 to 14, 2022.
   ProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q2 2022 Results - Earnings Call Transcript  2022/08/12 01:02:04 Seeking Alpha
ProPhase Labs, Inc (NASDAQ:NASDAQ:PRPH) Q2 2022 Earnings Conference Call August 11, 2022, 09:00 AM ET Company Participants Ted Karkus - Chairman & Chief Executive Officer Conference…
   ProPhase Labs GAAP EPS of $0.40 beats by $0.24, revenue of $29.09M beats by $5.77M  2022/08/11 12:10:37 Seeking Alpha
ProPhase Labs press release (NASDAQ:PRPH): Q2 GAAP EPS of $0.40 beats by $0.24.Revenue of $29.09M (+218.3% Y/Y) beats by $5.77M.Shares +4.96% PM.
   ProPhase Labs announced $6M buyback plan  2022/07/26 12:28:43 Seeking Alpha
ProPhase Labs (PRPH) stated Tuesday that it has received Board''s approval to repurchase up to $6M of its common shares. The buyback plan is to be effective three business days after…
   ProPhase Labs Stock: A Growth Stock At An Attractive Valuation (NASDAQ:PRPH)  2022/07/25 21:57:25 Seeking Alpha
ProPhase Labs has expanded its in-house testing capabilities for the diagnostics of the new clinical chemistry, immunoassay, hematology, hemostasis, and urinalysis analyzers.
   DSS stock pops on licensing deal with ProPhase Labs (NYSE:DSS)  2022/07/22 11:16:31 Seeking Alpha
DSS (DSS) shares popped around 17% after the company announced on Thursday the licensing of Impact BioMedical''s Linebacker portfolio to ProPhase Labs (PRPH).Global BioLife, a subsidiary…
   ProPhase Labs to license two investigational cancer compounds from Global BioLife  2022/07/21 13:33:44 Seeking Alpha
ProPhase Labs (PRPH) on Thursday said its unit had entered into a licensing agreement with Global BioLife for two inhibitors that can be used to treat multiple indications, with an…
   ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022  2022/07/19 12:30:00 Wallstreet:Online
Garden City, NY, July 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday, July 21, 2022, at 11:30 a.m. EST / 8:30 a.m. PST. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus, will host the webcast and review the latest developments at ProPhase Labs and
   ProPhase Labs Q4 2021 COVID-19 testing volumes surpass previous levels  2022/01/13 13:52:03 Seeking Alpha
ProPhase Labs (PRPH) announces that testing volumes exceeded well over 300,000 PCR COVID-19 tests during Q4 2021
   ProPhase Labs (NASDAQ:PRPH) Earns Buy Rating from Analysts at HC Wainwright  2021/12/22 06:24:42 Dakota Financial News
Investment analysts at HC Wainwright began coverage on shares of ProPhase Labs (NASDAQ:PRPH) in a report issued on Monday, Price reports. The brokerage set a buy rating and a $12.00 price target on the stock. HC Wainwrights target price indicates a potential upside of 52.09% from the stocks current price. A number of other []
   ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team  2021/12/16 13:30:00 Intrado Digital Media
Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio Miralles to EVP/ Chief Information Officer
   State Street Corp Invests $86,000 in ProPhase Labs, Inc. (NASDAQ:PRPH)  2021/12/13 09:12:45 Transcript Daily
State Street Corp purchased a new position in shares of ProPhase Labs, Inc. (NASDAQ:PRPH) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 13,795 shares of the companys stock, valued at approximately $86,000. State Street Corp owned 0.09% of ProPhase Labs at the end of []
   ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Sold by Northern Trust Corp  2021/12/06 09:06:51 Dakota Financial News
Northern Trust Corp trimmed its stake in ProPhase Labs, Inc. (NASDAQ:PRPH) by 42.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,850 shares of the companys stock after selling 14,939 shares during the quarter. Northern Trust Corp owned approximately 0.13% of ProPhase Labs worth []